Chiricozzi A, Costanzo A, Levi A, Parretta F, Ravasio R. Cost per NNT for upadacitinib in the treatment of patients with moderate-severe atopic dermatitis in Italy. Grhta [Internet]. 2024 Feb. 16 [cited 2024 Nov. 21];11(1):38-50. Available from: https://journals.aboutscience.eu/index.php/grhta/article/view/2728